Amino-Terminal Pro-B-Type Natriuretic Peptide Testing in Neonatal and Pediatric Patients

American Journal of Cardiology

Volumn 101, Issue 3 SUPPL., 2008, Pages

  Johns, Martin Christopher ^a   Stephenson, Carol ^a  

^a Gifford Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; DOXORUBICIN;

ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONGENITAL HEART DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EXPOSURE; EARLY LIFE ELEVATION; HEART FAILURE; HUMAN; NORMAL VALUE; PEDIATRICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK; TOXICITY; UMBILICAL CORD BLOOD;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE; HUMANS; INFANT; INFANT, NEWBORN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS;

EID: 38649099723     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.028     Document Type: Article

References (37)

1. Bar-Oz B., Lev-Sagie A., Arad I., Salpeter L., and Nir A. N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem 51 (2005) 926-927
2. Hammerer-Lercher A., Mair J., Tews G., Puschendorf B., and Sommer R. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 51 (2005) 913-915
3. Mir T.S., Laux R., Hellwege H.H., Liedke B., Heinze C., von Buelow H., Laer S., and Weil J. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112 (2003) 896-899
4. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 (2002) e76
5. Nir A., Bar-Oz B., Perles Z., Brooks R., Korach A., and Rein A.J. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence: elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93 (2004) 603-607
6. Albers S., Mir T.S., Haddad M., and Laer S. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability. Clin Chem Lab Med 44 (2006) 80-85
7. Mir T.S., Flato M., Falkenberg J., Haddad M., Budden R., Weil J., Albers S., and Laer S. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 27 (2006) 73-77
8. Schwachtgen L., Herrmann M., Georg T., Schwarz P., Marx N., and Lindinger A. Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children. Z Kardiol 94 (2005) 399-404
9. Soldin S.J., Soldin O.P., Boyajian A.J., and Taskier M.S. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 366 (2006) 304-308
10. Walther T., Stepan H., Pankow K., Gembardt F., Faber R., Schultheiss H.P., and Siems W.E. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus. BJOG 111 (2004) 452-455
11. Bakker J., Gies I., Slavenburg B., Bekers O., Delhaas T., and van Dieijen-Visser M. Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood. Clin Chem 50 (2004) 2465
12. Rauh M., and Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 49 (2003) 1563-1564
13. Yoshibayashi M., Kamiya T., Saito Y., Nakao K., Nishioka K., Temma S., Itoh H., Shirakami G., and Matsuo H. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 133 (1995) 207-209
14. Fede C., Frisina N., Caracciolo A., Buemi M., Caruso M.G., and Ricca M. Changes in plasma concentrations of atrial natriuretic peptide during the first ten days and the second month of life. Child Nephrol Urol 9 (1988) 144-146
15. Modi N., Betremieux P., Midgley J., and Hartnoll G. Postnatal weight loss and contraction of the extracellular compartment is triggered by atrial natriuretic peptide. Early Hum Dev 59 (2000) 201-208
16. Lin N.C., Landt M.L., Trinkaus K.M., Balzer D.T., Kort H.W., and Canter C.E. Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol 96 (2005) 847-850
17. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
18. Chang A.Y., Abdullah S.M., Jain T., Stanek H.G., Das S.R., McGuire D.K., Auchus R.J., and de Lemos J.A. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 49 (2007) 109-116
19. Cohen S., Springer C., Avital A., Perles Z., Rein A.J., Argaman Z., and Nir A. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?. Pediatrics 115 (2005) 1347-1350
20. Fried I., Bar-Oz B., Perles Z., Rein A.J., Zonis Z., and Nir A. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J Pediatr 149 (2006) 28-31
21. Geiger R., Hammerer-Lercher A., Url C., Schweigmann U., Puschendorf B., Sommer R., Stein J.I., and Mair J. NT-proBNP concentrations indicate cardiac disease in pediatric patients. Int J Cardiol 149 (2007) 28-31
22. Hammerer-Lercher A., Geiger R., Mair J., Url C., Tulzer G., Lechner E., Puschendorf B., and Sommer R. Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients. Clin Chem 52 (2006) 1415-1419
23. Nir A., and Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 11 suppl (2005) S76-S80
24. Nasser N., Perles Z., Rein A.J., and Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 27 (2006) 87-90
25. Fried I., Bar-Oz B., Algur N., Fried E., Gavri S., Yatsiv I., Perles Z., Rein A.J., Zonis Z., Bass R., and Nir A. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 118 (2006) e1165-e1168
26. Nasser N., Bar-Oz B., and Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 147 (2005) 248-253
27. Dodge-Khatami A., Buchel E.V., Knirsch W., Kadner A., Rousson V., Dave H.H., Bauersfeld U., and Pretre R. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 82 (2006) 983-988
28. Tulevski I.I., Dodge-Khatami A., Groenink M., van der Wall E.E., Romkes H., and Mulder B.J. Right ventricular function in congenital cardiac disease: noninvasive quantitative parameters for clinical follow-up. Cardiol Young 13 (2003) 397-403
29. Tulevski I.I., Groenink M., van Der Wall E.E., van Veldhuisen D.J., Boomsma F., Stoker J., Hirsch A., Lemkes J.S., and Mulder B.J. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 86 (2001) 27-30
30. Norozi K., Buchhorn R., Bartmus D., Alpers V., Arnhold J.O., Schoof S., Zoege M., Binder L., Geyer S., and Wessel A. Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of Fallot is due to biventricular dysfunction as determined by the myocardial performance index. Am J Cardiol 97 (2006) 1377-1382
31. Breuer T., Sapi E., Skoumal R., Toth M., Ala-Kopsala M., Vuolteenaho O., Leppaluoto J., Ruskoaho H., Szatmari A., and Szekely A. N-terminal probrain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation in neonates. Paediatr Anaesth 17 (2007) 782-788
32. Gessler P., Knirsch W., Schmitt B., Rousson V., and von Eckardstein A. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 148 (2006) 372-376
33. Mir T.S., Haun C., Lilje C., Laer S., and Weil J. Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery. Pediatr Cardiol 27 (2006) 209-216
34. Dore A., Houde C., Chan K.L., Ducharme A., Khairy P., Juneau M., Marcotte F., and Mercier L.A. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 112 (2005) 2411-2416
35. Ekstein S., Nir A., Rein A.J., Perles Z., Bar-Oz B., Salpeter L., Algur N., and Weintraub M. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children. J Pediatr Hematol Oncol 29 (2007) 440-444
36. Germanakis I., Kalmanti M., Parthenakis F., Nikitovic D., Stiakaki E., Patrianakos A., and Vardas P.E. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol 108 (2006) 212-215
37. Sandri M.T., Salvatici M., Cardinale D., Zorzino L., Passerini R., Lentati P., Leon M., Civelli M., Martinelli G., and Cipolla C.M. N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?. Clin Chem 51 (2005) 1405-1410